Argus lowers target to USD 102.00 for Innospec stock
Published on 10/17/2026 at 20:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTarget and reporting schedule
- Argus lowered its Innospec target to USD 102.00 on October 14, 2026.
- Second-quarter revenue grew 11.80 percent to USD 491.40 million.
- Innospec stock was USD 96.81 on October 16, 2026, up 0.22 percent on Nasdaq.
- Third-quarter earnings are scheduled for November 3, 2026, with the conference call on November 4, 2026.
Innospec stock (ISIN US45768S1050) has a fresh analyst target of USD 102.00 after Argus lowered its objective on October 14, 2026, according to Yahoo Finance. That target was 5.36 percent above the latest Nasdaq price of USD 96.81. Innospec was up 0.22 percent versus the prior Nasdaq close.
Argus target and price gap
The target update gives investors a defined valuation marker while the stock remains below the analyst objective. The comparison uses the same home-exchange currency: USD 102.00 against USD 96.81, producing a 5.36 percent gap above the price.
Revenue growth supports the picture
In the second quarter of 2026, revenue reached USD 491.40 million, up 11.80 percent from USD 439.70 million a year earlier, according to Benzinga. Net income was USD 30.80 million, compared with USD 23.50 million in the prior-year quarter. The transcript also reported adjusted earnings per share of USD 1.27, up from USD 1.26.
Price position and trading volume
The latest Nasdaq price sat 3.65 percent below the 52-week high of USD 100.48 and 47.77 percent above the low of USD 65.51. Trading volume was 173,644 shares against an average of 191,804 shares. Innospec's specialty chemical operations cover fuel additives, performance chemicals and oilfield services.
Valuation and reporting dates
Innospec had a market capitalization of USD 2.4 billion and a price-to-earnings ratio of 19.76 as of October 16, 2026. The company lists third-quarter earnings for November 3, 2026, followed by its conference call on November 4, 2026 at 9:00 a.m. EST, according to Innospec.
Comparison with peers
IOSP (Nasdaq, USD): plus 0.22 percent, P/E 19.76, market capitalization USD 2.4 billion
Albemarle (NYSE, USD): minus 2.75 percent, market capitalization USD 11.3 billion
LyondellBasell (NYSE, USD): plus 2.14 percent, P/E minus 57.67, market capitalization USD 20.7 billion
Stock stays below its yearly high
Innospec's price position combines a modest Nasdaq advance with a 3.65 percent distance from its 52-week high. The next scheduled earnings release on November 3, 2026 is the clearest upcoming date for a new operating comparison.
Innospec was last at USD 96.81 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, up 0.22 percent versus the prior Nasdaq close. The further course of trading is shown by the continuously updated real-time quote of Innospec stock.
Innospec market facts
- Company: Innospec Inc.
- ISIN: US45768S1050
- Ticker: IOSP
- Primary exchange: Nasdaq
- Last Nasdaq price: USD 96.81 (October 16, 2026, 4:00 p.m. ET)
- Change versus prior Nasdaq close: plus 0.22 percent
- Market capitalization: USD 2.4 billion (as of October 16, 2026)
- 52-week range: USD 65.51-100.48 (as of October 16, 2026)
- Sector / Industry: Basic Materials / Specialty Chemicals
- Next earnings date: November 3, 2026
Market context: Market report S&P 500.
